Hospitalization and medication use in schizophrenia patients receiving risperidone long-acting injectable or oral atypical antipsychotic medication

被引：3
|
作者：
Chue, P
Lam, A
Chandra, K
Luong, D
Camacho, F
机构：
[1] Univ Alberta, Edmonton, AB, Canada
[2] Janssen Ortho Inc, Toronto, ON, Canada
[3] McKesson Phase 4 Solut, Toronto, ON, Canada
[4] Damos Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67768-6
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A202 / A202
页数：1
相关论文
共 50 条
  • [41] Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge
    Marcus, Steven C.
    Zummo, Jacqueline
    Pettit, Amy R.
    Stoddard, Jeffrey
    Doshi, Jalpa A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2015, 21 (09): : 754 - 768
  • [42] Insight in stable patients with schizophrenia receiving long-acting risperidone
    Gharabawi, G
    Amador, XF
    Bossie, C
    Lasser, R
    Zhu, Y
    Ballenger, JC
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S401 - S401
  • [43] RISK OF BREAKTHROUGH SYMPTOMS ON ANTIPSYCHOTIC MEDICATION WHEN REMITTED PATIENTS WITH SCHIZOPHRENIA ARE TREATED WITH LONG-ACTING INJECTABLE MEDICATIONS: PRELIMINARY RESULTS
    Zipursky, Robert
    Agid, Ofer
    Remington, Gary
    Spandier, Olivia
    Sung, Nicole
    Chen, Sheng
    Wang, Wei
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 559 - 560
  • [44] Use of Long-Acting Injectable Antipsychotic Medication in Youth at Winnebago Mental Health Institute: A Clinical Pathway
    Scharko, Alexander M.
    Mireski, Sarah J.
    Casimir, Kenneth
    Goldstein, Benjamin
    Monese, George
    Pope, Kayla
    Taleon, Andrea
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2025, 35 (02) : 111 - 113
  • [45] Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
    Louza, Mario Rodrigues
    Elkis, Helio
    Ruschel, Sandra
    de Oliveira, Irismar Reis
    Bressan, Rodrigo Affonseca
    Belmonte-de-Abreu, Paulo
    Grabowski, Hamilton
    Appolinario, Jose Carlos
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 391 - 398
  • [46] Experiences in using risperidone long-acting injectable in aged patients with schizophrenia
    Harrington, Kathleen
    Onufryk, Josie
    INTERNATIONAL JOURNAL OF MENTAL HEALTH NURSING, 2008, 17 : A12 - A13
  • [47] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    Kane, John M.
    McEvoy, Joseph P.
    Correll, Christoph U.
    Llorca, Pierre-Michel
    CNS DRUGS, 2021, 35 (11) : 1189 - 1205
  • [48] Long-Acting Injectable Antipsychotic Medications in Patients With Comorbid Schizophrenia and Substance Use Disorders
    Green, Alan I.
    JOURNAL OF DUAL DIAGNOSIS, 2012, 8 (01) : 62 - 63
  • [49] Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia
    John M. Kane
    Joseph P. McEvoy
    Christoph U. Correll
    Pierre-Michel Llorca
    CNS Drugs, 2021, 35 : 1189 - 1205
  • [50] Long-Acting Injectable Antipsychotic Use in Patients with Schizophrenia and Criminal Justice System Encounters
    Bhatta, Madhav P.
    Bista, Saroj
    El Khoury, Antoine C.
    Hutzell, Eric G.
    Tandon, Neeta
    Smith, Douglas
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2021, 8 (01): : 63 - 70
12345